[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.236.145.124. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 3,211
Citations 0
Viewpoint
Innovations in Health Care Delivery
November 22/29, 2016

Achieving the Triple Aim Through Disruptive Innovations in Self-care

Author Affiliations
  • 1Internal Medicine, University of Texas Southwestern Medical Center, Dallas
  • 2Parkland Health and Hospital System, Dallas, Texas
 

Copyright 2016 American Medical Association. All Rights Reserved.

JAMA. 2016;316(20):2081-2082. doi:10.1001/jama.2016.15391

Innovations in biotechnology have had a significant influence on health care outcomes but often at increased costs. The new challenges facing the US health care system call for low-cost, affordable innovative solutions in delivery of services to achieve the triple aim: improving the experience of care, improving population health, and reducing the per capita costs of health care.

One such innovative approach is self-administered outpatient intravenous antibiotic treatment (OPAT). In this approach, patients who need intravenous antibiotics for up to 8 weeks are taught to self-administer antibiotics at home. The traditional treatment approach for these patients in the United States involves 1 of the following: supervised administration of intravenous antibiotics at an infusion center, administration at a skilled nursing facility, or administration at home with nursing assistance. These options represent the usual forms of OPAT.

×